Healthcare Industry Circulating Tumor Cells Market Analysis 2024

Your Catalyst To a Lucrative Business
Circulating Tumor Cells Market Analysis, Size, Share, Growth,
Research and Forecast to 2024 | Hexa Research
“Circulating tumor cells (CTC) market is expected to
grow over the forecast period owing to the increasing
prevalence of cancer and growing population.”
The Global Circulating Tumor Cells Market is primarily fueled by high incidence of cancer and other lifestyle
diseases, growing global population, and technological developments. CTCs are cancer cells that start drifting
away from metastatic or primary tumor sites and start circulating in the bloodstream. These are primarily
utilized in molecular analysis, such as liquid biopsies. Rising adoption of companion diagnost ic options &
personalized medicine for total eradication of onsite cancer could create lucrative opportunities for further
market progress.
The global industry is at present characterized by translational research and genomics. These systems lead to
better detection, analysis, and enumeration of circulating tumor cells present in patients. The need for
oncology diagnosis, screening, and therapy propels the overall industry. However, complexities in the
isolation of tumor cells can impede market growth during the forecast period (2016 to 2024).
Browse Details of Report@ https://www.hexaresearch.com/research-report/circulating-tumor-cells-
industry
Follow Us: